These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 15748779)
1. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease. Ma SL; Tang NL; Lam LC; Chiu HF Neurobiol Aging; 2005 Jul; 26(7):1005-10. PubMed ID: 15748779 [TBL] [Abstract][Full Text] [Related]
2. The combinations of TNFalpha-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease. Vural P; Değirmencioğlu S; Parildar-Karpuzoğlu H; Doğru-Abbasoğlu S; Hanagasi HA; Karadağ B; Gürvit H; Emre M; Uysal M Acta Neurol Scand; 2009 Dec; 120(6):396-401. PubMed ID: 19744138 [TBL] [Abstract][Full Text] [Related]
3. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease. Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004 [TBL] [Abstract][Full Text] [Related]
4. An association study of inflammatory cytokine gene polymorphisms in Fabry disease. Safyan R; Whybra C; Beck M; Elstein D; Altarescu G Eur Cytokine Netw; 2006 Dec; 17(4):271-5. PubMed ID: 17353161 [TBL] [Abstract][Full Text] [Related]
5. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe. Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028 [TBL] [Abstract][Full Text] [Related]
10. Association of -592C/A, -819C/T and -1082A/G interleukin-10 promoter polymorphisms with idiopathic recurrent spontaneous abortion. Zammiti W; Mtiraoui N; Cochery-Nouvellon E; Mahjoub T; Almawi WY; Gris JC Mol Hum Reprod; 2006 Dec; 12(12):771-6. PubMed ID: 17041236 [TBL] [Abstract][Full Text] [Related]
11. Genetic association between matrix metalloproteinase MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer's disease. Shibata N; Ohnuma T; Higashi S; Usui C; Ohkubo T; Kitajima A; Ueki A; Nagao M; Arai H Neurobiol Aging; 2005 Jul; 26(7):1011-4. PubMed ID: 15748780 [TBL] [Abstract][Full Text] [Related]
12. Gene dose-dependent association of interleukin-1A [-889] allele 2 polymorphism with Alzheimer's disease. Combarros O; Sánchez-Guerra M; Infante J; Llorca J; Berciano J J Neurol; 2002 Sep; 249(9):1242-5. PubMed ID: 12242547 [TBL] [Abstract][Full Text] [Related]
13. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease. Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y; Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596 [TBL] [Abstract][Full Text] [Related]
14. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms. Zappia M; Manna I; Serra P; Cittadella R; Andreoli V; La Russa A; Annesi F; Spadafora P; Romeo N; Nicoletti G; Messina D; Gambardella A; Quattrone A Arch Neurol; 2004 Mar; 61(3):341-4. PubMed ID: 15023809 [TBL] [Abstract][Full Text] [Related]
15. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population. Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578 [TBL] [Abstract][Full Text] [Related]
16. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation. Licastro F; Porcellini E; Caruso C; Lio D; Corder EH Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778 [TBL] [Abstract][Full Text] [Related]
17. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease. Licastro F; Chiappelli M; Grimaldi LM; Morgan K; Kalsheker N; Calabrese E; Ritchie A; Porcellini E; Salani G; Franceschi M; Canal N Neurobiol Aging; 2005 Apr; 26(4):449-53. PubMed ID: 15653173 [TBL] [Abstract][Full Text] [Related]
18. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease. Yao L; Li K; Zhang L; Yao S; Piao Z; Song L Brain Res; 2009 Sep; 1291():133-9. PubMed ID: 19631630 [TBL] [Abstract][Full Text] [Related]
19. Use of haplotype information to test involvement of the LRP gene in Alzheimer's disease in the French population. Verpillat P; Bouley S; Campion D; Hannequin D; Dubois B; Belliard S; Puel M; Thomas-Antérion C; Agid Y; Brice A; Clerget-Darpoux F Eur J Hum Genet; 2001 Jun; 9(6):464-8. PubMed ID: 11436129 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer's disease in a Polish population. Klimkowicz-Mrowiec A; Marona M; Wołkow P; Maruszak A; Styczynska M; Barcikowska M; Zekanowski C; Szczudlik A; Slowik A Dement Geriatr Cogn Disord; 2009; 28(5):461-4. PubMed ID: 19940477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]